Global Minimal Residual Disease (MRD) Testing Market Size & Trends Report Segmented by Offering (Assay Kits/Reagents, Instruments, Services), Technology (PCR, NGS), Application (Haematological Malignancies, Solid Tumours), End-user (Hospitals, Specialty Clinics), & Regional Forecast to 2031

Request Quote Download FREE Sample
Single User

Research Methodology

The study has been compiled based on extensive primary and secondary research.

Secondary Research (Indicative List)

Minimal Residual Disease Testing Market - Secondary Research

Primary Research

To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders. Supply Side Stakeholders:
  • Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
  • Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
  • Hospitals & Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes, and others

Breakdown of Primary Interviews

Minimal Residual Disease Testing Market - Primary InterviewsMarket Size Estimation

Both Top-Down & Bottom-Up Approaches were used to derive market size estimates and forecasts

Data Triangulation

Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Companys Sal